Multiple Targets Allergy Cleaner   MAF, a multi-target nutraceutical formulation, is developed based on the R&D platforms of anti-asthma new drug 1217B, which has passed the review by USA FDA on IND (Investigational New Drug). Asthma, allergic rhinitis and atopic dermatitis are all allergic diseases results from immune dysfunction. Besides avoiding allergens contact, we can also modulate our immune system to prevent the allergy attacks. The efficacy of MAF on immune modulation was proved via in vitro and in vivo assays. The result of these studies showed that MAF effectively reduced the rapid fluctuation of allergen-related biochemical indicators, modulated the immune system to prevent and alleviate allergic symptoms.   Characteristics   1.A pure and natural food formulation; safe, no side effects. 2.Effectively relieve inflammation and allergic reactions caused by allergens. 3.Effectively prevent the inflammatory cells infiltration, and avoid deformation of bronchi due to abnormal cell proliferation. 4.A multi-target anti allergic formula; effectively reduce the allergy and inflammation biochemical indicators IgE, TNF-α, IL-4, IL-5, and IL-13. Completed Studies of MAF   The efficacy of MAF formulation was validated following the R&D platforms of 1217B. In vivo study showed that MAF effectively reduced the biochemical indicators related to allergy and inflammation in sensitized mice’s serum including IgE, TNF-α, IL-4, IL-5, and IL-13 after administered with MAF for 21 days, and alleviated the infiltration of inflammatory cells to prevent the deformation of bronchus.